Showing results (531-540 of 640) with videos related to
Sort By:
Pageof 64
Cancer Research|December 6, 2006
HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancerVinata B Lokeshwar, Veronica Estrella, Luis Lopez, et al.The Journal of Urology|March 1, 1987
Endocrine and exocrine profiles of men with testicular tumors before orchiectomyP R Carroll, W F Whitmore, H W Herr, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantationZ Fuks, S A Leibel, K E Wallner, et al.British Journal of Urology|March 1, 1997
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II studyM S Cookson, P C Sogani, P Russo, et al.The Journal of Urology|May 1, 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49P C Brenner, W J Rettig, M P Sanz-Moncasi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancerR A Badalament, H W Herr, G Y Wong, et al.Urology|April 19, 2005
Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rateAlan M Nieder, Adrienne J K Carmack, Paul D Sved, et al.Urologic Oncology|December 23, 2008
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based surveyAlan M Nieder, Yair Lotan, Geoffrey R Nuss, et al.The Journal of Urology|March 1, 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reactionR S Israeli, W H Miller, S L Su, et al.Cancer|August 15, 1993
Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogenH Matzkin, M S Soloway, P F Schellhammer, et al.Pageof 64